267 related articles for article (PubMed ID: 21850627)
1. Epistaxis as the reason for premature discontinuation of clopidogrel after percutaneous coronary angioplasty with stent implantation.
Jura-Szołtys E; Chudek J
Kardiol Pol; 2011; 69(8):817-23. PubMed ID: 21850627
[TBL] [Abstract][Full Text] [Related]
2. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
3. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
[TBL] [Abstract][Full Text] [Related]
4. Observance of antiplatelet therapy after stent implantation in patients under chronic oral anticoagulant treatment.
Valencia J; Mainar V; Bordes P; Pineda J; Gómez S; Sogorb F
J Interv Cardiol; 2008 Jun; 21(3):218-24. PubMed ID: 18422520
[TBL] [Abstract][Full Text] [Related]
5. Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel.
Pasceri V; Patti G; Pristipino C; Pelliccia F; Irini D; Varveri A; Roncella A; Di Sciascio G; Speciale G
Catheter Cardiovasc Interv; 2010 May; 75(6):936-42. PubMed ID: 20146326
[TBL] [Abstract][Full Text] [Related]
6. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation.
Rossini R; Capodanno D; Lettieri C; Musumeci G; Nijaradze T; Romano M; Lortkipanidze N; Cicorella N; Biondi Zoccai G; Sirbu V; Izzo A; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ
Am J Cardiol; 2011 Jan; 107(2):186-94. PubMed ID: 21211596
[TBL] [Abstract][Full Text] [Related]
8. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
11. Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year.
Ferreira-González I; Marsal JR; Ribera A; Permanyer-Miralda G; García-Del Blanco B; Martí G; Cascant P; Masotti-Centol M; Carrillo X; Mauri J; Batalla N; Larrousse E; Martín E; Serra A; Rumoroso JR; Ruiz-Salmerón R; de la Torre JM; Cequier A; Gómez-Hospital JA; Alfonso F; Martín-Yuste V; Sabatè M; García-Dorado D
J Am Coll Cardiol; 2012 Oct; 60(15):1333-9. PubMed ID: 22999716
[TBL] [Abstract][Full Text] [Related]
12. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients.
Tavassoli N; Voisin S; Carrie D; Lapeyre-Mestre M; Galinier M; Montastruc JL; Pathak A
Am J Cardiovasc Drugs; 2010; 10(1):29-35. PubMed ID: 20104932
[TBL] [Abstract][Full Text] [Related]
13. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
Eshtehardi P; Windecker S; Cook S; Billinger M; Togni M; Garachemani A; Meier B; Hess OM; Wenaweser P
Am Heart J; 2010 May; 159(5):891-898.e1. PubMed ID: 20435201
[TBL] [Abstract][Full Text] [Related]
14. Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents.
Lemesle G; Torguson R; Bonello L; de Labriolle A; Maluenda G; Ben-Dor I; Collins SD; Syed AI; Xue Z; Satler LF; Pichard AD; Waksman R
EuroIntervention; 2011 Apr; 6(9):1053-9. PubMed ID: 21518676
[TBL] [Abstract][Full Text] [Related]
15. Stent thrombosis is associated with an impaired response to antiplatelet therapy.
Wenaweser P; Dörffler-Melly J; Imboden K; Windecker S; Togni M; Meier B; Haeberli A; Hess OM
J Am Coll Cardiol; 2005 Jun; 45(11):1748-52. PubMed ID: 15936599
[TBL] [Abstract][Full Text] [Related]
16. Reasonable duration of Clopidogrel use after drug-eluting stent implantation in Korean patients.
Shin DH; Chae IH; Youn TJ; Cho SI; Kwon DA; Suh JW; Chang HJ; Cho YS; Chung WY; Choi YJ; Gwon HC; Han KR; Choi DJ
Am J Cardiol; 2009 Dec; 104(12):1668-73. PubMed ID: 19962472
[TBL] [Abstract][Full Text] [Related]
17. Timing of thrombotic events in patients receiving 2 weeks of clopidogrel therapy post bare metal coronary artery stenting: a New Zealand retrospective study.
Tie S; Wong CK; Yap J; Wilkins G; Williams M; Kay P
N Z Med J; 2007 Jun; 120(1255):U2553. PubMed ID: 17546101
[TBL] [Abstract][Full Text] [Related]
18. Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation.
Rogacka R; Chieffo A; Michev I; Airoldi F; Latib A; Cosgrave J; Montorfano M; Carlino M; Sangiorgi GM; Castelli A; Godino C; Magni V; Aranzulla TC; Romagnoli E; Colombo A
JACC Cardiovasc Interv; 2008 Feb; 1(1):56-61. PubMed ID: 19393145
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
[TBL] [Abstract][Full Text] [Related]
20. Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.
Roy P; Bonello L; Torguson R; de Labriolle A; Lemesle G; Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2008 Dec; 102(12):1614-7. PubMed ID: 19064014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
